1461565 Ontario Inc. (Chinese name: 1461565 安大略省公司) guarantees that the information provided to the company is true, accurate, and complete, without false records, misleading statements, or significant omissions. The company and all members of the board guarantee that the announcement content is consistent with the information provided by the information disclosure obligor.
Securities Code: 301089
Securities Abbreviation: Tuoxin Pharmaceutical
Announcement Number: 2026-039
Tuoxin Pharmaceutical Group Co., Ltd. Announcement on Pre-disclosure of Share Reduction Plan by Shareholders Holding More Than 5%
Special Reminder: Shareholder 1461565 Ontario Inc., which holds 17,297,407 shares (accounting for 13.67% of the company's total share capital), plans to reduce its holdings through block trading by no more than 2,530,890 shares, representing no more than 2% of the company's total share capital, within three months starting from fifteen trading days after this announcement (i.e., from June 29, 2026, to September 28, 2026). The company recently received a notification letter regarding the share reduction plan from shareholder 1461565 Ontario Inc. The actual controller, Ms. Xu Yingmin, is the spouse of the company's director, Mr. Xian Shenglin. The relevant information is announced as follows:
1. Basic Information of the Shareholder
| Shareholder Name | Number of Shares Held (shares) | Percentage of Total Share Capital (%) |
|---|---|---|
| 1461565 Ontario Inc. | 17,297,407 | 13.67 |